Evaluation of application rationality of Extract of Ginkgo Biloba Leaves Injection based on weighted TOPSIS method
Objective To establish the rules for evaluating the drug utilization of Extract of Ginkgo Biloba Leaves Injection,and to evaluate the rationality of clinical use of Extract of Ginkgo Biloba Leaves Injection based on weighted TOPSIS method,so as to provide a reference basis for promoting its rational use in the clinic.Methods Based on the instruction manual of Extract of Ginkgo Biloba Leaves Injection,guidelines,consensus and related literature,formulated the rules for the evaluation of drug utilization,and evaluated 228 medical records using it from January to December 2023 in Bozhou People's Hospital by the weighted TOPSIS method.Results Among the 228 medical records,there were 65 cases(28.51%)of reasonable medical records(Ci≥0.8),125 cases(54.82%)of basically reasonable(0.6≤Ci<0.8),and 38 cases(16.67%)of unreasonable medical records(Ci<0.6).The main manifestations of irrational drug use included 91 cases(39.91%)of the course of administration,78 cases(34.21%)of infusion speed,52 cases(22.81%)of interaction,47 cases(20.61%)of exceeding the medical insurance limitation,31 cases(13.60%)of exceeding the indication,28 cases(12.28%)of medication monitoring,and 25 cases(10.96%)of pre-medication assessment.Conclusion The rationality evaluation approach of Extract of Ginkgo Biloba Leaves Injection based on the weighted TOPSIS method is simple and feasible,and the evaluation results are more intuitive and reasonable.The results showed that the clinical use of the drug is more unreasonable,and hospitals need to strengthen the intervention,with a view to promoting rational clinical use.
Extract of Ginkgo Biloba Leaves Injectionweighted TOPSIS methodattribute hierarchical modelrationality evaluationindication of exceeding medical insurance limit